U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H8N2
Molecular Weight 108.1411
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Phenylhydrazine

SMILES

NNC1=CC=CC=C1

InChI

InChIKey=HKOOXMFOFWEVGF-UHFFFAOYSA-N
InChI=1S/C6H8N2/c7-8-6-4-2-1-3-5-6/h1-5,8H,7H2

HIDE SMILES / InChI

Molecular Formula C6H8N2
Molecular Weight 108.1411
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26717206 | https://www.ncbi.nlm.nih.gov/pubmed/6732840

Phenylhydrazine (also known as the hydrazinobenzene) is an industrial substance suspect of carcinogenic potential for humans. Phenylhydrazine was the first hydrazine derivative characterized, reported by Emil Fischer in 1875. Phenyl-hydrazine is used to prepare indoles via the Fischer Indole Synthesis, which are intermediates in the synthesis of various dyes and pharmaceuticals. This molecule is also used to induce acute hemolytic anemia in animal models. Exposure to phenylhydrazine may cause contact dermatitis, hemolytic anemia, and liver damage.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
230.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Kinetics and mechanism of the nucleophilic displacement reactions of chloroacetanilide herbicides: investigation of alpha-substituent effects.
2004-05-19
Erythroid cells in immunoregulation: characterization of a novel suppressor factor.
2004-05-15
Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
2004-05-06
Matrix-assisted laser desorption/ionization tandem mass spectrometry and post-source decay fragmentation study of phenylhydrazones of N-linked oligosaccharides from ovalbumin.
2004-05
Effect of alkyl-beta,d-glucopyranosides on hypertonic haemolysis of erythrocytes.
2004-05
Synthesis and characterization of zinc sensors based on a monosubstituted fluorescein platform.
2004-04-19
A sulfido-bridged diiron(II) compound and its reactions with nitrogenase-relevant substrates.
2004-04-14
S-stereoselective piperazine-2-tert-butylcarboxamide hydrolase from Pseudomonas azotoformans IAM 1603 is a novel L-amino acid amidase.
2004-04
Interaction of TRPC2 and TRPC6 in erythropoietin modulation of calcium influx.
2004-03-12
Fast-flow EPR spectroscopic observation of the isoniazid, iproniazid, and phenylhydrazine hydrazyl radicals.
2004-02
Gestational diabetes affects platelet behaviour through modified oxidative radical metabolism.
2004-01
Upregulation in the expression of multidrug resistance protein Mrp1 mRNA and protein by increased bilirubin production in rat.
2003-11-28
[Activity of key enzymes of heme metabolism and cytochrome P-450 content in the rat liver in experimental rhabdomyolysis and hemolytic anemia].
2003-10-28
Profiling of N-linked oligosaccharides using phenylhydrazine derivatization and mass spectrometry.
2003-10-17
Formation of meso, N-diphenylprotoporphyrin IX by an aerobic reaction of phenylhydrazine with oxyhemoglobins.
2003-10
An NMR and X-ray study of the structure of the azo coupling product of 4-dimethylaminopent-3-en-2-one and benzenediazonium-tetrafluoroborate.
2003-09-21
Tandem hydroformylation/Fischer indole synthesis: a novel and convenient approach to indoles from olefins.
2003-09-04
Structure of the phenylhydrazine adduct of the quinohemoprotein amine dehydrogenase from Paracoccus denitrificans at 1.7 A resolution.
2003-09
Amperometric and spectrophotometric determination of carbaryl in natural waters and commercial formulations.
2003-09
Labelling saccharides with phenylhydrazine for electrospray and matrix-assisted laser desorption-ionization mass spectrometry.
2003-08-05
Optosensing behavior of the first Ru(II)-compound of di-2-pyridylketone-p-nitrophenylhydrazone (dpknph), [Ru(bpy)2(dpknph)]Cl2.
2003-07
Synthesis of new chiral 2,2'-bipyridine ligands and their application in copper-catalyzed asymmetric allylic oxidation and cyclopropanation.
2003-06-13
Nucleophilic substitution reactions of alpha-chloroacetanilides with benzylamines in dimethyl sulfoxide.
2003-06-07
Synthesis and characterization of model compounds of the lysine tyrosyl quinone cofactor of lysyl oxidase.
2003-05-21
Pharmaco-economical analysis of the treatment with antibiotics in a surgery department.
2003-05
Synthesis of some new pyrimidine and fused pyrimidine derivatives (Part I).
2003-04-23
Hematopoietic capacity of connexin43 wild-type and knock-out fetal liver cells not different on wild-type stroma.
2003-04-15
Inactivation of bovine plasma amine oxidase by 4-aryloxy-2-butynamines and related analogs.
2003-04-11
Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine.
2003-04-11
Synthesis of some new pyrimidine and fused pyrimidine derivatives (Part 2).
2003-04
Isolation of 4-chloro-3-formyl-2-(2-hydroxyethene-1-yl) quinolines by Vilsmeier Haack reaction on quinaldines: Construction of diazepino quinoline heterocycles and their antimicrobial and cytogenetic studies.
2003-03
Saturation transfer in human red blood cells with normal and unstable hemoglobin.
2003-02
Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: comparison with hydralazine.
2003-01
The fate of dolichol in rat cells and tissues.
2003
Haemoglobin biosynthesis site in rabbit embryo erythroid cells.
2003
[Metabolism of heme and hemeproteins and some indices of the antioxidant system in rat erythrocytes and tissues under anemia caused by phenylhydrazine].
2003
The microrheological changes in the course of erythrocyte senescence after phenylhydrazine injection.
2003
The influence of Sacoglottis gabonensis stem bark extract and its isolate bergenin, Nigerian alcoholic beverage additives, on the metabolic and haematological side effects of 2,4-dinitrophenyl hydrazine-induced tissue damage.
2002-12
Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry.
2002-12
Analysis of heme oxygenase isomers in rat.
2002-12
[The immunometaboic effects of benfotiamine and riboxine on hemolytic anemia].
2002-11-27
Mutation of alphaPhe55 of methylamine dehydrogenase alters the reorganization energy and electronic coupling for its electron transfer reaction with amicyanin.
2002-11-26
Stability of agaritine - a natural toxicant of Agaricus mushrooms.
2002-11
Synthesis, structural characterization and antimicrobial studies of hydrazone derivatives of 3-hydroxyimino-5-methyl-2-hexanone.
2002-10-31
Revisiting the Ullmann-ether reaction: a concise and amenable synthesis of novel dibenzoxepino[4,5-d]pyrazoles by intramolecular etheration of 4,5-(o,o'-halohydroxy)arylpyrazoles.
2002-10-18
C-C bond formation via C-H bond activation: synthesis of the core of teleocidin B4.
2002-10-09
Phenylhydrazide as an enzyme-labile protecting group in peptide synthesis.
2002-10-04
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.
2002-10
Influence of storage and household processing on the agaritine content of the cultivated Agaricus mushroom.
2002-09
The role of thyroid hormone on phenylhydrazine hydrochloride mediated inhibitory effects on blood acetylcholinesterase: an in vivo and in vitro study.
2002
Patents

Sample Use Guides

In experimental mice, phenylhydrazine (PHZ; 60 mg/kg body weight; Sigma Chem, St. Louis, MO) was injected intraperitoneally for 2 consecutive days.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Blood was drawn from healthy donors using 3.13% sodium citrate as the anticoagulant (1: 5, v/v). Cells were isolated using isoosmotic phosphate-buffered saline (PBS, pH 7,4), microcrystalline cellulose and Lu-cellulose (1: 1, w/w) as described by Beutler et al. Red blood cells were suspended in PBS and preincubated in glass test-tubes in a shaking water bath for 1 hr at 37C, after which haematocrit was adjusted to 2.5% by adding PBS. Samples containing hemoglobin were adjusted to 8 mg/ml hemoglobin in PBS, i.e. a concentration comparable to that used in experiments with red cells. Varying amounts of phenylhydrazine, ranging from 0.5 to 50 mM were added to the red blood cell or hemoglobin samples. Then 3 ml of each sample was aliquoted into 10 ml headspace vials, and the vials were immediately sealed with special air-tight rubber septums. Headspaces were flushed with hydrocarbon-free synthetic air for 2 min in order to replace laboratory air containing small amounts of hydrocarbons. The sealed samples were then incubated in a shaking water bath at 37C. After certain periods, 1 ml of the gas phase was drawn with a gas-tight syringe and injected into the gas chromatograph.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:56:32 GMT 2025
Edited
by admin
on Mon Mar 31 18:56:32 GMT 2025
Record UNII
064F424C9K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Phenylhydrazine
HSDB   MI   WHO-DD  
Systematic Name English
PHENYLHYDRAZINE [HSDB]
Preferred Name English
HYDRAZINOBENZENE
Systematic Name English
PHENYLHYDRAZINE [MI]
Common Name English
Phenylhydrazine [WHO-DD]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
202-873-5
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
CAS
100-63-0
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
RXCUI
8167
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY RxNorm
EPA CompTox
DTXSID8021147
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
MESH
C030299
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
CHEBI
27924
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
WIKIPEDIA
PHENYLHYDRAZINE
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
HSDB
1117
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
SMS_ID
300000053580
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
MERCK INDEX
m8674
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY Merck Index
PUBCHEM
7516
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
FDA UNII
064F424C9K
Created by admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY